UNSPSC 51281653: Kanamycin a

This classification denotes an aminoglycoside antibiotic with the molecular formula C18H36N4O11, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier EQK9Q303C5, chemically known as d-streptamine, o-3-amino-3-deoxy-.alpha.-d-glucopyranosyl-(1->6)-o-(6-amino-6-deoxy-.alpha.-d-glucopyranosyl-(1->4))-2-deoxy-, but more generally known as kanamycin a, which bears US NIH Compound Identifier 6032.

European Medicines Agency schedules kanamycin a or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08362MIG. Most nations, for tariff purposes, schedule kanamycin a under HS 29419000. Kanamycin a bears US NLM identifiers UMLS ID C0022489 and NCI Concept Code C76151. SMILES: C1[C@H]([C@@H]([C@H]([C@@H]([C@H]1N)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CN)O)O)O)O)O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)N)O)N.

UNSPSC 51281653 Kanamycin a is a Commodity code for a specific pharmaceutical active ingredient, but recent state and local procurements tagged to this code do not reflect purchases of kanamycin itself. Instead, the opportunities listed show state and local health agencies sourcing finished pharmaceutical products — antibiotics, opioid antagonists, and drug deactivation equipment — through piggyback cooperative purchasing vehicles and competitive sealed bidding. The Illinois Department of Public Health awarded a $2,999,999.11 contract through the MMCAP Infuse consortium to Chartwell Rx LLC for Doxycycline Hyclate 100mg and Ciprofloxacin Hydrochloride 500mg tablets under an Invitation for Bid process, while Seminole County, Florida sought annual supplies of 1,900 units of naloxone and 800 safe drug deactivation systems through an IFB with quarterly deliveries to its community health building. These procurements signal that state and local health departments and county public-health entities are active buyers of pharmaceutical inventory through both cooperative-purchasing frameworks and direct competitive processes.

Activity under this code spans Florida and Illinois, with the Illinois procurement representing a substantial multi-year award and the Florida solicitation reflecting ongoing community-health inventory needs. The Seminole County IFB specified e-Procurement Portal submission, E-Verify compliance, drug-free workplace certification, and fixed-fee pricing with a two-year term and one-year renewal option; the Illinois award followed lowest-priced responsive-and-responsible evaluation with no set-aside requirements. Neither opportunity required Business Enterprise or Veterans Business Program participation. The mismatch between the code's nominal scope (kanamycin a, a specific antibiotic chemical) and the actual procurements (finished dosage forms and ancillary health products) suggests that this code may be routinely misapplied in state and local tagging, or that procurement volume under the true commodity is minimal relative to broader pharmaceutical-procurement activity.